Funny you should mention "printing machines"
Currency titan Crane & Co., headquartered in Boston, is being sold for $800 million to a Connecticut company with a similar name. The company has strong…
www.wamc.org
This Annemarie Watson gets around formally of Crane Currency
She's now with this company.
The below article was unable to be shared so I copied a Snippet of it for later digging into.
WOBURN, Mass., August 01, 2022--(
BUSINESS WIRE)--Covaris, LLC ("Covaris" or "the Company"), a manufacturer of advanced tools enabling life science innovations, announced today that it has appointed Annemarie Watson as Chief Executive Officer, effective immediately. Ms. Watson succeeds Covaris founder Jim Laugharn, who will remain an investor in Covaris and on serve on the Company’s Board of Directors, as well as assuming the role of Chief Technology Officer. Annemarie brings to Covaris a wealth of leadership experience in life sciences and other technology-intensive industries, and a passion for leading innovation and growth.
Most recently, Ms. Watson served as Senior Vice President of Clinical Diagnostics for Eurofins Scientific, where she was responsible for the North American Clinical Diagnostics segment with 1,500 employees across 21 laboratories serving 10 businesses. Previously, she was President of Crane Currency, the global leader in anti-counterfeiting technology solutions. Prior to her time at Crane Currency, Annemarie served as Vice President Business Process Improvement and Global Supply Chain at MDS Inc. (now Nordion), where she served businesses such as radiopharmaceuticals, pharma services and mass spectrometry. She has also held leadership roles at Honda of Canada Manufacturing, and the Boston Consulting Group.
"We are thrilled to welcome Annemarie and believe that her broad leadership experience in life sciences and technology-intensive industries will be instrumental in our success through our next phase of growth," said Christopher O’Connell, Executive Chairman of the Covaris Board of Directors and Senior Advisor at New Mountain Capital. "We look forward to working with Annemarie as we leverage Covaris’ leading biomolecule extraction technology to accelerate life sciences innovation."
"I am grateful to have been given the opportunity to lead Covaris, a leader in the life sciences industry with a strong culture of innovation," said Annemarie Watson, Chief Executive Officer of Covaris. "I have been incredibly impressed with Covaris’ market-leading technology and look forward to working with our team and our partners at New Mountain Capital to expand our capabilities, help bring our technology to more customers, and continue to cement our place as the preeminent sample prep platform for multiple discovery and analytical workflows."
Leading provider of Cobalt-60 and gamma irradiation systems for medical device, food safety and health care industries and innovative applications.
www.nordion.com